01 ADENOSINE (2)
01 ASTELLAS (2)
01 SOLUTION;INTRAVENOUS (2)
01 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (2)
19
Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ADENOSINE, with a corresponding application number 20059 and regulatory information .
proudly manufactured in the
approval since 1995-05-18
Astellas Pharma's ADENOSCAN SOLUTION;INTRAVENOUS, medication with 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ADENOSINE.
18
Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ADENOSINE, with a corresponding application number 20059 and regulatory information .
proudly manufactured in the
approval since 1995-05-18
Astellas Pharma's ADENOSCAN SOLUTION;INTRAVENOUS, medication with 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ADENOSINE.